Home › NDC Lookup › RxCUI directory › RxCUI 884526

Dextroamphetamine sulfate 1 MG/ML Oral Solution [ProCentra] — RxCUI 884526

RxNorm drug concept · Semantic branded drug
RxCUI 884526 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI884526
Official nameDextroamphetamine sulfate 1 MG/ML Oral Solution [ProCentra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProCentra 1 MG/ML Oral Solution; ProCentra 5 MG in 5 mL Oral Solution; ProCentra 5 MG per 5 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)8,232 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextroamphetamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It sounds counterintuitive, but stimulants actually calm things down for many people with ADHD. Dextroamphetamine boosts dopamine and norepinephrine — two brain chemicals involved...
  • What exactly does dextroamphetamine do, and why does a stimulant help with ADHD?
  • The most common ones are decreased appetite, trouble sleeping, and headache — and decreased appetite is very common, especially early on. Taking doses too late in the day tends to...
  • What are the most common side effects I should expect?
📖 Read our full Dextroamphetamine guide →

🕸️ Concept Web — How Dextroamphetamine sulfate 1 MG/ML Oral Solution... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dextroamphetamine sulfate 1 MG/ML Oral Solution [ProCentra] RxCUI 884526

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dextroamphetamine 3288
    • Dextroamphetamine sulfate 3287
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • ProCentra 847176
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dextroamphetamine Oral Solution 757335
    • Dextroamphetamine sulfate Oral Solution 2649051
    • Dextroamphetamine Oral Liquid Product 1154564
    • Dextroamphetamine Oral Product 1154565
    • Dextroamphetamine sulfate Oral Liquid Product 2661663
    • Dextroamphetamine sulfate Oral Product 2662479
    • Dextroamphetamine Oral Solution [ProCentra] 847178
    • Dextroamphetamine sulfate Oral Solution [ProCentra] 2655145
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dextroamphetamine sulfate 1 MG/ML Oral Solution SCD · 884522
  • Dextroamphetamine sulfate 1 MG/ML SCDC · 884521
  • Dextroamphetamine Oral Solution SCDF · 757335
  • Dextroamphetamine sulfate Oral Solution SCDFP · 2649051
  • Dextroamphetamine Oral Liquid Product SCDG · 1154564
  • Dextroamphetamine Oral Product SCDG · 1154565
  • Dextroamphetamine sulfate Oral Liquid Product SCDGP · 2661663
  • Dextroamphetamine sulfate Oral Product SCDGP · 2662479

Brand-Name Concepts

  • Dextroamphetamine sulfate 1 MG/ML [ProCentra] SBDC · 884525
  • Dextroamphetamine Oral Solution [ProCentra] SBDF · 847178
  • Dextroamphetamine sulfate Oral Solution [ProCentra] SBDFP · 2655145
  • ProCentra Oral Liquid Product SBDG · 1179518
  • ProCentra Oral Product SBDG · 1179519
  • ProCentra BN · 847176

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 884526 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21724-0701-05 473 mL in 1 BOTTLE, PLASTIC (21724-701-05) PROCENTRA INDEPENDENCE PHARMACEUTICALS, LLC 2014-05-15
Observed labelers: INDEPENDENCE PHARMACEUTICALS, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.6222
Range $1.6222–$1.6222 · middle 50% $1.6222–$1.6222 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.